Effect of lixisenatide on natriuretic peptides in people with type 2 diabetes and recent acute coronary syndrome: The ELIXA trial

Affiliations

• ¹ Population Health Research Institute, Hamilton Health Sciences and McMaster University, Hamilton, Ontario, Canada.
• ² Department of Cardiology, Herlev-Gentofte Hospital, Copenhagen, Denmark.
• ³ Department of Medicine, Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts, USA.
• ⁴ Estudios Clínicos Latino América (ECLA) and Instituto Cardiovascular de Rosario, Rosario, Argentina.
• ⁵ University of Bergen, Stavanger University Hospital, Stavanger, Norway.
• ⁶ Sanofi Global Medical Diabetes, Frankfurt, Germany.
• ⁷ Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
• ⁸ ANMCO Research Center, Heart Care Foundation, Florence, Italy.
• ⁹ British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
• ¹⁰ Division of Cardiology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.
• ¹¹ Oregon Health & Science University, Portland, Oregon, USA.
• ¹² Montreal Heart Institute, Université de Montréal, Montreal, Quebec, Canada.